… markers in convalescent COVID-19 individuals over time To determine the levels of monocyte
activation markers in convalescent COVID-19 … seven groups of COVID-19 individuals. As …

… with COVID‐19 on admission, compared with HVs. (A) and (B) Distribution of patients with
COVID‐19 in … to disease severity of patients with COVID‐19 on admission compared with HVs: …

… of COVID-19 patients, aiming to identify predictive factors of in-hospital mortality. Methods
COVID-19 … Markers of endothelium activation including von-Willebrand factor (vWF), soluble …

… markers. Albumin levels (serum and urine) and serum total protein estimation can be used
as predictive markers in COVID-19. … applicable biochemical markers useful in COVID-19, the …

… our results, that past COVID-19 infection may influence functioning of the nervous system. …
to measure renal injury markers in mild-to-moderate COVID-19 convalescents. We found no …

… markers would resolve over time in survivors, particularly in individuals treated with
COVID-19-related therapy. We hypothesize that increases in neuroinflammation markers can be …

… markers in hospitalized patients with COVID-19. … Coronavirus 2 infection and hospitalized
due to COVID-19 … immunoserological markers in patients with COVID-19 pneumonia …

… These data indicate that COVID-19, similar to some chronic infections, damages the function
… We therefore further performed cluster analysis on marker expression using data obtained …

… inflammatory markers and the severity of COVID-19 among patients. … COVID-19, however,
is unknown [17]. In current study, we aimed to analyze the inflammatory markers of COVID-19 …

… In order to predict the specificity of these abnormalities to COVID-19 disease, we compared
their incidence in 50 patients admitted to the hospital having non-COVID-19–related health …